Saturday 17 October 2026
Export OGN’s income statement to Excel — free account
Organon & Co.
OGN Healthcare Drug Manufacturers General
Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024. In the quarter to June 2026, revenue fell 2.26%, EPS fell 26.8%, free cash flow fell 83.0% and total debt fell 3.86%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
13.76
0.00
0.00%
Follow OGN
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 4 | 5 | 4 | — | — | — | — |
P/E ratio |
9.96 | 4.45 | 3.66 | 7.80 | 5.71 | 4.54 | 4.54 | 4.54 | 4.54 |
Altman Z-Score |
1.09 | 1.27 | 1.26 | 1.51 | 1.52 | — | — | — | — |
P/S ratio |
0.30 | 0.60 | 0.60 | 1.16 | 1.22 | 1.35 | 1.35 | 1.35 | 1.35 |
Altman Z″-Score (non-manufacturers) |
1.78 | 1.81 | 1.68 | 1.64 | 1.41 | — | — | — | — |
P/FCF ratio |
4.48 | 5.78 | 8.29 | 13.09 | 3.91 | 3.39 | 3.39 | 3.39 | 3.39 |
Beneish M-Score |
(2.68) | (2.62) | (2.21) | (2.40) | (3.56) | (2.93) | — | — | — |
P/Operating CF |
13.20 | 9.83 | 9.46 | 26.71 | 164.26 | 6.48 | 6.48 | 6.48 | 6.48 |
Dividend Safety Score |
45 | — | — | — | — | — | — | — | — |
P/B ratio |
2.47 | 8.13 | 0.00 | 0.00 | 0.00 | 1.79 | 1.79 | 1.79 | 1.79 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.60 | 1.88 | 1.89 | 2.48 | 2.56 | 1.49 | 1.49 | 1.49 | 1.49 |
EV/EBITDA |
6.92 | 7.24 | 7.92 | 8.61 | 8.38 | 3.75 | 3.75 | 3.75 | 3.75 |
EV/Operating CF |
14.19 | 12.82 | 14.80 | 17.88 | 7.46 | 3.40 | 3.40 | 3.40 | 3.40 |
EV/FCF |
23.93 | 18.16 | 26.10 | 28.15 | 8.16 | 3.76 | 3.76 | 3.76 | 3.76 |
Quick Ratio |
0.80 | 0.75 | 0.84 | 0.87 | 0.82 | 0.39 | 1.34 | 1.20 | — |
Current Ratio |
1.82 | 1.60 | 1.54 | 1.56 | 1.45 | 1.33 | 2.95 | 2.40 | — |
Net Debt/EBITDA |
5.62 | 4.94 | 5.40 | 4.61 | 4.69 | 0.01 | (0.05) | (0.02) | 0.00 |
Debt/Assets |
67.18% | 67.78% | 72.65% | 81.36% | 85.52% | 0.31% | 1.12% | 0.00% | 0.00% |
Debt/Equity |
11.49 | 18.81 | (125.14) | (9.99) | (6.06) | 0.01 | 0.02 | 0.00 | — |
Asset Turnover |
0.48 | 0.51 | 0.54 | 0.57 | 0.61 | 0.63 | 1.47 | 0.00 | 0.00 |
Operating CF/Net income |
3.74 | 1.09 | 0.78 | 0.94 | 1.60 | 1.06 | 0.94 | 1.71 | 1.90 |
Capex/Depreciation |
(0.47) | (0.96) | (1.07) | (1.48) | (1.93) | (1.76) | (0.26) | (0.04) | 0.00 |
Interest Coverage |
1.63 | 2.64 | 2.39 | 3.72 | 6.94 | 174.75 | 194.53 | 129.95 | 261.76 |
| 30.56% | 429.85% | (212.68%) | (76.42%) | 67.92% | 34.50% | 48.09% | 32.18% | 0.00% | |
| 1.44% | 6.87% | 8.89% | 8.48% | 13.00% | 20.91% | 61.02% | 0.00% | 0.00% | |
ROIC |
5.84% | 9.90% | 9.82% | 13.41% | 16.25% | 31.74% | 33.80% | 0.00% | — |
Return on Tangible Assets |
5.73% | 30.88% | 36.89% | 37.63% | 63.25% | 115.02% | 97.69% | 76.35% | 0.00% |
Average Days of Receivables |
78.16 | 77.41 | 101.64 | 87.20 | 80.02 | 58.00 | 69.18 | 59.92 | 0.00 |
Research and Development Expense of Revenue |
5.89% | 7.32% | 8.43% | 7.63% | 5.38% | 3.21% | 2.83% | 3.73% | 3.38% |
Selling, General and Administrative Expense of Revenue |
27.69% | 27.49% | 30.23% | 27.60% | 26.46% | 20.76% | 18.55% | 20.59% | 21.76% |
Intangible Assets out of Total Assets |
0.41 | 0.47 | 0.43 | 0.48 | 0.49 | 0.51 | 0.49 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1.24% | 1.64% | 1.61% | 1.21% | 0.94% | 0.61% | 0.53% | 0.57% | 0.00% |
Graham Net Nets |
(4.17) | (2.16) | (2.03) | (1.11) | (1.09) | (0.23) | (0.23) | (0.23) | (0.23) |
Graham Number |
6.85 | 11.76 | 0.00 | 0.00 | 0.00 | 64.41 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
10.04% | 22.45% | 27.33% | 12.83% | 17.50% | 22.04% | 22.04% | 22.04% | 22.04% |
Free Cash Flow Yield |
22.30% | 17.29% | 12.07% | 7.64% | 25.58% | 29.46% | 29.46% | 29.46% | 29.46% |
Revenue per Share |
23.95 | 24.91 | 24.54 | 24.30 | 24.86 | 25.77 | 30.68 | 38.64 | 41.50 |
Operating CF per Share |
2.70 | 3.65 | 3.13 | 3.38 | 8.52 | 9.01 | 11.91 | 14.57 | 13.51 |
Capex per Share |
(1.10) | (1.07) | (0.99) | (1.23) | (1.49) | (0.99) | (0.35) | (0.27) | 0.00 |
Free Cash Flow per Share |
1.60 | 2.58 | 2.14 | 2.15 | 7.03 | 8.02 | 11.57 | 14.30 | 13.51 |
Cash per Share |
2.21 | 2.63 | 2.72 | 2.78 | 2.91 | 0.05 | 1.26 | 0.96 | 0.00 |
Shareholders Equity per Share |
2.90 | 1.84 | (0.27) | (3.51) | (5.95) | 21.64 | 27.75 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.90 | 1.84 | (0.27) | (3.51) | (5.95) | 21.64 | 27.75 | 0.00 | 0.00 |
Free Cash Flow |
415.00 | 663.00 | 547.00 | 545.00 | 1,783.00 | 2,034.00 | 2,932.00 | 3,618.00 | 3,419.00 |
Working Capital |
1,962.00 | 1,630.00 | 1,590.00 | 1,419.00 | 1,163.00 | 894.00 | 2,614.00 | 2,169.00 | — |
Capital Expenditures |
(285.00) | (276.00) | (252.00) | (313.00) | (377.00) | (250.00) | (88.00) | (69.00) | (86.00) |
Net Current Asset Value |
(7,763.00) | (8,281.00) | (7,620.00) | (7,916.00) | (8,429.00) | (1,056.00) | 442.00 | 3,714.00 | — |
EV/EBIT |
12.05 | 8.76 | 9.40 | 9.77 | 9.00 | 4.01 | 4.01 | 4.01 | 4.01 |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.05 | 0.06 | 0.04 | 0.01 | 0.01 | 0.00 |
Price to Operating Income |
2.26 | 2.79 | 2.99 | 4.54 | 4.31 | 3.63 | 3.63 | 3.63 | 3.63 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.47 | 0.25 | 0.20 | 0.21 | 0.20 | 0.14 | 0.49 | 2.57 | 0.00 |
Cash ROIC |
4.16% | 6.61% | 5.83% | 6.24% | 21.32% | 36.79% | 39.24% | 920.61% | 0.00% |
Accounts Receivable Turnover |
4.62 | 4.13 | 3.89 | 4.32 | 5.21 | 5.20 | 5.05 | 6.35 | 0.00 |
Accounts Payable Turnover |
2.76 | 2.18 | 2.06 | 1.83 | 2.90 | 8.20 | 8.31 | 17.16 | 0.00 |
Inventory Turnover |
2.13 | 2.04 | 2.17 | 2.39 | 2.61 | 2.14 | 2.20 | 4.55 | 0.00 |
Average Days of Payables |
119.70 | 156.56 | 190.70 | 180.11 | 211.77 | 44.61 | 41.41 | 22.48 | 0.00 |
Days of Inventory on Hand |
176.78 | 179.38 | 190.84 | 159.59 | 140.21 | 157.27 | 171.91 | 77.31 | 0.00 |
Average Receivables |
1,344.50 | 1,551.00 | 1,609.50 | 1,428.50 | 1,210.00 | 1,256.00 | 1,539.50 | 1,539.50 | — |
Average Payables |
1,052.50 | 1,233.50 | 1,223.00 | 1,257.00 | 820.50 | 258.50 | 273.50 | 273.50 | — |
Average Inventory |
1,363.50 | 1,318.00 | 1,159.00 | 959.00 | 914.00 | 992.00 | 1,032.50 | 1,032.50 | — |
Average Assets |
12,984.00 | 12,579.50 | 11,506.50 | 10,818.00 | 10,395.00 | 10,328.50 | 5,274.00 | 0.00 | — |
Average Common Equity |
612.00 | 201.00 | (481.00) | (1,200.00) | 1,989.00 | 6,260.50 | 6,691.50 | 6,691.50 | — |
Columns are period end dates